Life Science Investing Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts
Life Science Investing Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
Life Science Investing Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors
Life Science Investing Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference
Homerun Resources Inc. Announces Listing of Its Shares on Tradegate Exchange in Germany Increasing European and International Market Liquidity
